Immuneering CorporationIMRXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P83
Within normal range
vs 2Y Ago
14.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.85% |
| Q3 2025 | -26.84% |
| Q2 2025 | 32.94% |
| Q1 2025 | 2.96% |
| Q4 2024 | -7.74% |
| Q3 2024 | -16.60% |
| Q2 2024 | 25.57% |
| Q1 2024 | -29.99% |
| Q4 2023 | 1.14% |
| Q3 2023 | -11.53% |
| Q2 2023 | 25.00% |
| Q1 2023 | -22.24% |
| Q4 2022 | -7.28% |
| Q3 2022 | -14.57% |
| Q2 2022 | 22.44% |
| Q1 2022 | -33.98% |
| Q4 2021 | -2.28% |
| Q3 2021 | -40.09% |
| Q2 2021 | -4.89% |
| Q1 2021 | -12.11% |
| Q4 2020 | -57.27% |
| Q3 2020 | -3.53% |
| Q2 2020 | -45.46% |
| Q1 2020 | 0.00% |